113 related articles for article (PubMed ID: 17099625)
1. Is cytarabine required in the treatment of acute promyelocytic leukemia? Updated experience and review of the literature.
Adès L; Fenaux P
Clin Adv Hematol Oncol; 2006 Sep; 4(9):678-82. PubMed ID: 17099625
[No Abstract] [Full Text] [Related]
2. Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group.
Adès L; Chevret S; Raffoux E; de Botton S; Guerci A; Pigneux A; Stoppa AM; Lamy T; Rigal-Huguet F; Vekhoff A; Meyer-Monard S; Maloisel F; Deconinck E; Ferrant A; Thomas X; Fegueux N; Chomienne C; Dombret H; Degos L; Fenaux P;
J Clin Oncol; 2006 Dec; 24(36):5703-10. PubMed ID: 17116939
[TBL] [Abstract][Full Text] [Related]
3. Cuban experience in the treatment of acute promyelocytic leukemia with ALL transretinoic acid followed by intensive chemotherapy.
Hernández P; Martinez G; Losada R; Machín S; Cayado N; Gramatges A
Haematologica; 2002 Mar; 87(3):ELT14. PubMed ID: 11869960
[No Abstract] [Full Text] [Related]
4. [The biological characteristics and treatment of acute promyelocytic leukemia].
Savchenko VG; Parovichnikova EN; Isaev VG; Demidova IA; Kuliev RG; Gribanova EO; Kliasova GA; Kucher RA; Sokolov AN; Momotiuk KS; Ol'shanskaia IuV; Tiurina NG; Tikhonova LIu; Galstian GM; Budianskiĭ VM; Belousov EA; Lapin VA; Voloshin SV; Konstaninova TS; Filatov LB; Porokhina ON; Smirnova EA
Ter Arkh; 1998; 70(7):5-11. PubMed ID: 9742627
[No Abstract] [Full Text] [Related]
5. The expanding role of arsenic in acute promyelocytic leukemia.
Tallman MS
Semin Hematol; 2008 Jul; 45(3 Suppl 2):S25-9. PubMed ID: 18760708
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy induced esophageal stricture.
Kassam A; Mandel K
Pediatr Blood Cancer; 2009 Apr; 52(4):551. PubMed ID: 19061235
[No Abstract] [Full Text] [Related]
7. Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature.
Betancourt-García RD; Castro J; Fernández AC; López-Enríquez A; Fradera J; Pacheco E
P R Health Sci J; 2009 Jun; 28(2):146-50. PubMed ID: 19530558
[TBL] [Abstract][Full Text] [Related]
8. Treatment of acute promyelocytic leukemia.
Arlin ZA; Feldman EJ
Blood; 1989 Oct; 74(5):1858. PubMed ID: 2790209
[No Abstract] [Full Text] [Related]
9. Risk-adapted maintenance therapy for acute promyelocytic leukemia.
Nagai S; Takahashi T; Kurokawa M
J Clin Oncol; 2010 Jan; 28(2):e21; author reply e22-3. PubMed ID: 19949004
[No Abstract] [Full Text] [Related]
10. [Leukemia cutis in acute promyelocytic leukemia].
del Río Garma J; Varela Gómez MR; Torres Carrete JP; Batlle Fonrodona FJ
Sangre (Barc); 1997 Feb; 42(1):87-8. PubMed ID: 9229813
[No Abstract] [Full Text] [Related]
11. Significance of persistent Auer rods and cytogenetic abnormality after first cycle of therapy for acute promyelocytic leukaemia.
Dalal BI; Bruyere H; Barnett MJ
Br J Haematol; 2007 Jun; 137(5):385. PubMed ID: 17374141
[No Abstract] [Full Text] [Related]
12. Relapse and death during first remission in acute myeloid leukemia.
Yanada M; Garcia-Manero G; Borthakur G; Ravandi F; Kantarjian H; Estey E
Haematologica; 2008 Apr; 93(4):633-4. PubMed ID: 18379012
[No Abstract] [Full Text] [Related]
13. Aplastic anemia surfacing after treatment of acute promyelocytic leukemia: The Dameshek riddle.
Nabhan C; Radhakrishnan A
Clin Adv Hematol Oncol; 2009 Oct; 7(10):672-4. PubMed ID: 20040908
[No Abstract] [Full Text] [Related]
14. FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience.
Candoni A; Simeone E; Tiribelli M; Malagola M; Russo D; Fanin R
Am J Hematol; 2009 Oct; 84(10):690-2. PubMed ID: 19731308
[No Abstract] [Full Text] [Related]
15. Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia.
Roboz GJ; Ritchie EK; Curcio T; Provenzano J; Carlin R; Samuel M; Wittenberg B; Mazumdar M; Christos PJ; Mathew S; Allen-Bard S; Feldman EJ
Cancer; 2008 Nov; 113(9):2504-11. PubMed ID: 18825661
[TBL] [Abstract][Full Text] [Related]
16. Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients.
Camera A; Rinaldi CR; Palmieri S; Cantore N; Mele G; Mettivier V; Miraglia E; Mastrullo L; Grimaldi F; Luciano L; Guerriero A; Rotoli B; Ferrara F
Ann Hematol; 2009 Feb; 88(2):151-8. PubMed ID: 18709502
[TBL] [Abstract][Full Text] [Related]
17. Therapy-related acute promyelocytic leukemia after treatment with radioiodine for thyroid cancer: case report with literature review.
Grudeva-Popova J; Yaneva M; Zisov K; Ananoshtev N
J BUON; 2007; 12(1):129-32. PubMed ID: 17436415
[TBL] [Abstract][Full Text] [Related]
18. Extensive myelofibrosis responsive to treatment for acute erythroblastic leukaemia.
Fadilah SA; Raja-Zahratul-Azma RS; Leong CF
Malays J Pathol; 2006 Jun; 28(1):55-8. PubMed ID: 17694960
[TBL] [Abstract][Full Text] [Related]
19. Atypical presentation of retinoic acid syndrome that mimics septic arthritis in a patient with acute promyelocytic leukemia.
Akoz AG; Engin H; Oztoprak N
Acta Oncol; 2007; 46(8):1193-4. PubMed ID: 17851840
[No Abstract] [Full Text] [Related]
20. [Treatment of acute myeloid leukemia--focusing on the data from JALSG studies].
Miyawaki S
Rinsho Ketsueki; 2008 Oct; 49(10):1386-93. PubMed ID: 18833923
[No Abstract] [Full Text] [Related]
[Next] [New Search]
